Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus

被引：0
|
作者：
Jensen, Simon Kok
Heide-Jorgensen, Uffe
Andersen, Ina Trolle
Thomsen, Reimar
Christiansen, Christian Fynbo
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.111
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
462
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Risk of diabetic microvascular complications, heart failure, hospitalisation and all-cause mortality with SGLT2i and GLP1-ra in type 2 diabetes: a real-world data study
    Eleftheriadou, A.
    Riley, D.
    Austin, P.
    Hernandez, G.
    Alam, U.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S74 - S74
  • [32] GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity
    Stumpf, M.
    Dar, S. A.
    Rao, S.
    Doyle, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 999 - 999
  • [33] CARDIO-VASCULAR RISK STRATIFICATION IN T2DIABETES IN ITALY AND USE OF NEW DRUGS (SGLT2I AND GLP1-RA):DATA FROM THE AMD ANNALS
    Manicardi, V.
    Russo, G.
    Rocca, A.
    Rossi, M.
    Suraci, C.
    Pintaudi, B.
    Di Cianni, G.
    Di Bartolo, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [34] Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
    Koike, Masao
    Saito, Hitoki
    Kohno, Genta
    Takubo, Masahiro
    Watanabe, Kentaro
    Ishihara, Hisamitsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [35] The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study
    Wu, Tingting
    Wong, Carlos K. H.
    Tang, Eric H. M.
    Man, Kenneth K. C.
    Wong, Simon K. H.
    Au, Ivan Chi Ho
    Tse, Emily T. Y.
    Chan, Esther W. Y.
    Grieve, Eleanor
    Wu, Olivia
    Ng, Enders K. W.
    Wong, Ian C. K.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (06) : 762 - 771
  • [36] Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA
    King, Aaron
    Tan, Xi
    Dhopeshwarkar, Neil
    Bohn, Rhonda
    Dea, Katherine
    Leonard, Charles E.
    de Havenon, Adam
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (05)
  • [37] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Khat, Dorrin Zarrin
    Husain, Mansoor
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [38] Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
    Ritsinger, Viveca
    Avander, Kamila
    Lagerqvist, Bo
    Lundman, Pia
    Norhammar, Anna
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [39] GLP1RA Compared to SGLT2i Improves Depression Parameters in Veterans
    Jain, Arad
    Ubalde, Shannen Nicole
    Esper, Layal
    Powell, Joseph
    Meyer, Kristin
    Sen, Sabyasachi
    OBESITY, 2023, 31 : 87 - 88
  • [40] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Dorrin Zarrin Khat
    Mansoor Husain
    Current Diabetes Reports, 2018, 18
12345